Magnetic resonance imaging for distinguishing ovarian clear cell carcinoma from high-grade serous carcinoma

J Ovarian Res. 2016 Jul 4;9(1):40. doi: 10.1186/s13048-016-0251-x.

Abstract

Background: To compare the magnetic resonance imaging (MRI) features of ovarian clear cell carcinoma (CCC) and high-grade serous carcinoma (HGSC), to distinguish CCC from HGSC.

Methods: MRI features (laterality, shape, size, configuration, papillary projection, signal intensity, enhancement, peritoneal implant, lymphadenopathy, ascites) of 40 tumors in 37 patients with CCC, confirmed by surgery and pathology, were compared with those of 62 tumors in 40 patients with HGSC. Statistical analysis was performed using Mann-Whitney and Fisher's exact tests.

Results: There was a statistically significant difference in the mean maximum diameter, laterality, and FIGO stage (P = 0.002, P < 0.001, P < 0.001, respectively) between CCC and HGSC. Compared to HGSCs, CCCs were more frequently oval (30/40, 75 % vs 12/62, 19 %; P < 0.001), more often cystic (21/40, 53 % vs 8/62, 13 %; P < 0.001) and unilocular (23/29, 79 % vs 7/31, 23 %; P < 0.001), had T1-hyperintense cystic components more often (18/29, 62 % vs 5/29, 17 %; P < 0.001), had larger papillary projections (5.13 ± 0.4 cm vs 2.91 ± 0.3 cm; P < 0.001), were peritoneally implanted less frequently (P = 0.001) and had fewer ascites (P < 0.001).

Conclusions: CCC typically showed an oval, unilocular cystic mass with large papillary projection and T1-hyperintense cystic components. MRI could be helpful for distinguishing CCC from HGSC.

Keywords: Clear cell carcinoma; High-grade serous carcinoma; Magnetic resonance imaging; Ovary.

MeSH terms

  • Adenocarcinoma, Clear Cell / diagnostic imaging*
  • Adenocarcinoma, Clear Cell / pathology
  • Adenocarcinoma, Clear Cell / surgery
  • Biomarkers, Tumor
  • Cystadenocarcinoma, Serous / diagnostic imaging*
  • Cystadenocarcinoma, Serous / pathology
  • Cystadenocarcinoma, Serous / surgery
  • Diagnosis, Differential
  • Female
  • Humans
  • Image Enhancement
  • Image Processing, Computer-Assisted
  • Magnetic Resonance Imaging*
  • Menopause
  • Middle Aged
  • Neoplasm Staging
  • Ovarian Neoplasms / diagnostic imaging*
  • Ovarian Neoplasms / pathology
  • Reproducibility of Results
  • Tumor Burden

Substances

  • Biomarkers, Tumor